- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 403/12 - Derivatives of cyclohexane or of a cyclohexene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms by esterified hydroxy groups
Patent holdings for IPC class C07C 403/12
Total number of patents in this class: 44
10-year publication summary
|
0
|
1
|
1
|
1
|
8
|
4
|
5
|
2
|
0
|
3
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| DSM IP Assets B.V. | 5572 |
15 |
| University of Washington | 2358 |
5 |
| Eastman Chemical Company | 2213 |
4 |
| Chanel Parfums Beaute | 270 |
3 |
| Case Western Reserve University | 1842 |
2 |
| Wanhua Chemical Group Co., Ltd. | 354 |
2 |
| Translate bio, Inc. | 416 |
2 |
| BASF SE | 21036 |
1 |
| Adisseo France S.A.S. | 145 |
1 |
| Astex Therapeutics Limited | 242 |
1 |
| Cancer Research Technology Limited | 525 |
1 |
| Cognitive Research Enterprises, Inc. | 10 |
1 |
| Fudan University | 700 |
1 |
| Ind-Swift Laboratories Limited | 56 |
1 |
| Ohio State Innovation Foundation | 2191 |
1 |
| Shenzhen Hujia Technology Co., Ltd. | 36 |
1 |
| Retinagenix Holdings LLC | 1 |
1 |
| Eluminex Biosciences (Suzhou) Limited | 9 |
1 |
| Other owners | 0 |